2614 PUBLICATIONS
ANNÉE
JOURNAL
PREMIER AUTEUR
TITRE
ANNÉE2023
JOURNALJournal of medicinal chemistry
PREMIER AUTEURGodard A
TITRENIR-II Aza-BODIPY Dyes Bioconjugated to Monoclonal Antibody Trastuzumab for Selective Imaging of HER2-Positive Ovarian Cancer.
ANNÉE2023
JOURNALBioconjugate chemistry
PREMIER AUTEURPrivat M
TITREFirst Comparison Study of the and Properties of a Randomly and Site-Specifically Conjugated SPECT/NIRF Monomolecular Multimodal Imaging Probe (MOMIP) Based on an aza-BODIPY Fluorophore.
ANNÉE2023
JOURNALBMC medical research methodology
PREMIER AUTEURBotta L
TITREA new cure model that corrects for increased risk of non-cancer death: analysis of reliability and robustness, and application to real-life data.
ANNÉE2023
JOURNALInternational review of cell and molecular biology
PREMIER AUTEURBaude J
TITRECombining radiotherapy and NK cell-based therapies: The time has come.
ANNÉE2023
JOURNALEuropean journal of cancer (Oxford, England : 1990)
PREMIER AUTEURBascoul-Mollevi C
TITRENeoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER PRODIGE 23): Health-related quality of life longitudinal analysis.
ANNÉE2023
JOURNALPancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
PREMIER AUTEURBrugel M
TITREAssociation of palliative care management and survival after chemotherapy discontinuation in patients with advanced pancreatic adenocarcinoma: A retrospective single-centre observational study.
ANNÉE2023
JOURNALCancers
PREMIER AUTEURMeunier S
TITREElevated Baseline Neutrophil Count Correlates with Worse Outcomes in Patients with Muscle-Invasive Bladder Cancer Treated with Chemoradiation.
ANNÉE2023
JOURNALInternational journal of molecular sciences
PREMIER AUTEURDubois-Pot-Schneider H
TITRETranscriptomic Study on Human Skin Samples: Identification of Two Subclasses of Actinic Keratoses.
ANNÉE2023
JOURNALEuropean journal of applied physiology
PREMIER AUTEURHucteau E
TITREExacerbated central fatigue and reduced exercise capacity in early-stage breast cancer patients treated with chemotherapy.
ANNÉE2023
JOURNALPharmaceutics
PREMIER AUTEURLerouge L
TITRETargeting Glioblastoma-Associated Macrophages for Photodynamic Therapy Using AGuIX-Design Nanoparticles.

Retrouvez aussi

Personnes
Equipes
Plateformes
Unités de recherche, établissements
Projets de recherche
Publications scientifiques